Mouse Anti-CCNA1 Recombinant Antibody (E70.1) (CBMAB-XB0125-YC)

Bourova-Flin, E., Derakhshan, S., Goudarzi, A., Wang, T., Vitte, A. L., Chuffart, F., ... & Aminishakib, P. (2021). The combined detection of Amphiregulin, Cyclin A1 and DDX20/Gemin3 expression predicts aggressive forms of oral squamous cell carcinoma. British Journal of Cancer, 125(8), 1122-1134.

Tsao, C. H., Hsieh, W. C., Yang, R. Y., Lo, Y. H., Tu, T. J., Ke, L. Y., ... & Liu, F. T. (2021). Galectin-12 modulates sebocyte proliferation and cell cycle progression by regulating cyclin A1 and CDK2. Glycobiology.

Ge, M., Xu, Q., Kang, T., Li, D., Wang, R., Chen, Z., ... & Liu, H. (2021). Deubiquitinating enzyme inhibitor alleviates cyclin A1‐mediated proteasome inhibitor tolerance in mixed‐lineage leukemia. Cancer science, 112(6), 2287-2298.

Leung, W. K., Workineh, A., Mukhi, S., Tzannou, I., Brenner, D., Watanabe, N., ... & Lulla, P. (2020). Evaluation of cyclin A1–specific T cells as a potential treatment for acute myeloid leukemia. Blood advances, 4(2), 387-397.

Radonova, L., Pauerova, T., Jansova, D., Danadova, J., Skultety, M., Kubelka, M., & Anger, M. (2020). Cyclin A1 in Oocytes Prevents Chromosome Segregation And Anaphase Entry. Scientific reports, 10(1), 1-12.

He, X., Li, S., Shi, W., Lin, Q., Ma, J., Liu, Y., ... & Cao, X. (2019). Cyclin A1 is associated with poor prognosis in oesophageal squamous cell carcinoma. Oncology letters, 18(1), 706-712.

Pandey, S., Moazam, M., Ghimirey, N., Kuerbitz, S. J., & Fraizer, G. C. (2019). WT1 regulates cyclin A1 expression in K562 cells. Oncology reports, 42(5), 2016-2028.

Cao, J., Dong, J., Wang, Y., & Chen, Y. (2019). The expressions of DNA methyltransferase 1 (DNMT1) and cyclin A1 (CCNA1) in cervical carcinogenesis. International journal of clinical and experimental pathology, 12(1), 40.

Panigrahi, S. K., Manterola, M., & Wolgemuth, D. J. (2017). Meiotic failure in cyclin A1-deficient mouse spermatocytes triggers apoptosis through intrinsic and extrinsic signaling pathways and 14-3-3 proteins. PLoS One, 12(3), e0173926.

Lulla, P., Tzannou, I., Brenner, D., Heslop, H. E., Vera, J. F., & Leen, A. M. (2017). Evaluating Cyclin A1 As an Immunotherapeutic Target in Acute Myeloid Leukemia (AML). Blood, 130, 1907.

Please try the standard protocols which include: protocols, troubleshooting and guide.

Enzyme-linked Immunosorbent Assay (ELISA)
Flow Cytometry
Immunofluorescence (IF)
Immunohistochemistry (IHC)
Immunoprecipitation (IP)
Western Blot (WB)
Enzyme Linked Immunospot (ELISpot)
Proteogenomic
Other Protocols